Table 4.
1-year prevalence of primary IgAN in Germany
| Year | Lower bound | Upper bound | ||||||
|---|---|---|---|---|---|---|---|---|
| per 100,000 | Absolute number | per 100,000 | Absolute number | |||||
| n | 95 % CI lower limit | 95 % CI upper limit | n | 95 % CI lower limit | 95 % CI upper limit | |||
| 2017 | 4.3 | 3525 | 3010 | 4102 | 37.8 | 31,278 | 29,706 | 32,912 |
| 2018 | 4.4 | 3629 | 3102 | 4219 | 38.2 | 31,672 | 30,077 | 33,331 |
| 2019 | 4.6 | 3814 | 3270 | 4423 | 39.1 | 32,477 | 30,849 | 34,169 |
| 2020 | 4.3 | 3570 | 3040 | 4166 | 37.7 | 31,313 | 29,701 | 32,990 |
| 2021 | 4.4 | 3700 | 3149 | 4320 | 38.9 | 32,353 | 30,680 | 34,093 |
| 2022 | 4.8 | 4043 | 3463 | 4693 | 38.2 | 32,229 | 30,551 | 33,976 |